{ "params": { "ind": "药品及生物科技", "sort": "ygc", "page": 1, "q": "", "sig": false, "fcf": "", "screen": false, "big": false, "mine": false }, "pages": 2, "count": 170, "fcf_counts": { "all": 170, "end": 18, "yoy": 3, "trend": 19 }, "cap_counts": { "all": 170, "big": 34 }, "mine_counts": { "all": 170, "mine": 0 }, "watch_count": 0, "watch_updated": null, "triggered": 7, "details_updated_bj": "2026-10-17 13:54", "universe_updated_bj": "2026-10-17 13:49", "quotes_updated_bj": "2026-10-17 14:00", "quote_source": "腾讯", "a_updated_bj": "2026-10-17 14:00", "hkd_cny": 0.8517, "ah_count": 176, "main_period": "2026-06-30", "coverage": { "2026-06-30": 1995, "2025-06-30": 47, "2026-03-31": 403, "2024-12-31": 15, "2026-01-31": 7, "2025-12-31": 26, "2026-04-30": 15, "2025-10-31": 1, "2026-02-28": 23, "2025-09-30": 4, "2025-03-31": 4, "2026-09-30": 3, "2026-05-31": 8 }, "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "missing": [], "rows": [ { "code": "01889", "name": "三爱健康集团", "l1": "药品及生物科技", "l2": "非H股", "price": 0.142, "market_cap_yi": 0.2, "ev_yi": -0.4, "ee": null, "loss": true, "ygc": 27.11, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 2.47, "cash_yi": 3.15, "np_ttm_yi": -0.19, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -0.4, -0.6, 3.2, 0.1, -0.5 ], "fcf_avg_yi": 0.36000000000000004, "ibd_yi": 0.49, "k": 0.866, "k_src": "equity", "iv_yi": 5.4211599999999995 }, "revenue_ttm_yi": 0.83, "net_margin": -22.9, "roe_by_year": { "2023": 7.3065, "2024": 1.6684, "2025": -7.1068 }, "roe_avg": 0.62, "common_equity_yi": 1.6976, "pb": 0.12, "roe_pb": 5.29, "watched": false }, { "code": "02325", "name": "云康集团", "l1": "药品及生物科技", "l2": "非H股", "price": 0.585, "market_cap_yi": 3.1, "ev_yi": 3.8, "ee": 6.2, "loss": false, "ygc": 7.04, "triggered": true, "fcf_growth": [], "detail": { "total_liabilities_yi": 15.28, "cash_yi": 14.6, "np_ttm_yi": 0.61, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 1.4, -1.8, 2.7, 2.3, 2.5 ], "fcf_avg_yi": 1.42, "ibd_yi": 6.88, "k": 0.995, "k_src": "equity", "iv_yi": 21.810399999999998 }, "revenue_ttm_yi": 5.41, "net_margin": 11.3, "roe_by_year": { "2023": -4.4035, "2024": -48.6322, "2025": 0.254 }, "roe_avg": -17.59, "common_equity_yi": 11.5794, "pb": 0.27, "roe_pb": -65.72, "watched": false }, { "code": "06833", "name": "兴科蓉医药", "l1": "药品及生物科技", "l2": "非H股", "price": 0.145, "market_cap_yi": 2.5, "ev_yi": 13.9, "ee": 46.5, "loss": false, "ygc": 4.39, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 13.99, "cash_yi": 2.55, "np_ttm_yi": 0.3, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 2.8, 0.2, 2.9, -2.9, 1.8 ], "fcf_avg_yi": 0.9600000000000002, "ibd_yi": 1.17, "k": 1, "k_src": "profit", "iv_yi": 10.98 }, "revenue_ttm_yi": 19.21, "net_margin": 1.6, "roe_by_year": { "2023": 6.8761, "2024": 6.5139, "2025": 5.1369 }, "roe_avg": 6.18, "common_equity_yi": 7.1101, "pb": 0.35, "roe_pb": 17.56, "watched": false }, { "code": "00950", "name": "李氏大药厂", "l1": "药品及生物科技", "l2": "非H股", "price": 1.055, "market_cap_yi": 5.3, "ev_yi": 15.5, "ee": 14.9, "loss": false, "ygc": 3.51, "triggered": false, "fcf_growth": [ "end", "trend" ], "detail": { "total_liabilities_yi": 13.34, "cash_yi": 3.16, "np_ttm_yi": 1.04, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 1.4, 2.4, 0.7, 1.8, 2.5 ], "fcf_avg_yi": 1.7600000000000002, "ibd_yi": 2.17, "k": 1, "k_src": "equity", "iv_yi": 18.590000000000003 }, "revenue_ttm_yi": 13.55, "net_margin": 7.7, "roe_by_year": { "2023": 0.8427, "2024": 5.045, "2025": 4.9728 }, "roe_avg": 3.62, "common_equity_yi": 18.4593, "pb": 0.29, "roe_pb": 12.61, "watched": false }, { "code": "02877", "name": "神威药业", "l1": "药品及生物科技", "l2": "非H股", "price": 7.44, "market_cap_yi": 52.4, "ev_yi": -0.5, "ee": -0.1, "loss": false, "ygc": 2.97, "triggered": true, "fcf_growth": [ "end", "trend" ], "detail": { "total_liabilities_yi": 22.49, "cash_yi": 75.38, "np_ttm_yi": 8.04, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 6.1, 9.8, 7.9, 8.2, 9.7 ], "fcf_avg_yi": 8.34, "ibd_yi": 3.12, "k": 1, "k_src": "profit", "iv_yi": 155.66 }, "revenue_ttm_yi": 26.64, "net_margin": 30.2, "roe_by_year": { "2023": 14.4516, "2024": 11.5856, "2025": 12.2347 }, "roe_avg": 12.76, "common_equity_yi": 82.0615, "pb": 0.64, "roe_pb": 19.98, "watched": false }, { "code": "08329", "name": "海王英特龙", "l1": "药品及生物科技", "l2": "H股 · 创业板", "price": 0.097, "market_cap_yi": 1.4, "ev_yi": 2.8, "ee": null, "loss": true, "ygc": 2.34, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 3.6, "cash_yi": 2.12, "np_ttm_yi": -0.53, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -0.8, 0.4, 0.4, 0, 1.2 ], "fcf_avg_yi": 0.24, "ibd_yi": 0.96, "k": 0.922, "k_src": "equity", "iv_yi": 3.2823200000000003 }, "revenue_ttm_yi": 9.12, "net_margin": -5.8, "roe_by_year": { "2023": 2.6924, "2024": 2.7169, "2025": -5.1548 }, "roe_avg": 0.08, "common_equity_yi": 6.545, "pb": 0.21, "roe_pb": 0.4, "watched": false }, { "code": "00570", "name": "中国中药", "l1": "药品及生物科技", "l2": "红筹股", "price": 1.21, "market_cap_yi": 51.9, "ev_yi": 89.8, "ee": null, "loss": true, "ygc": 2.13, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 76.74, "cash_yi": 34.02, "np_ttm_yi": -10.1, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -0.8, 5.7, 6.8, 20.7, 19.6 ], "fcf_avg_yi": 10.4, "ibd_yi": 13.41, "k": 0.887, "k_src": "equity", "iv_yi": 110.52907000000002 }, "revenue_ttm_yi": 127.2, "net_margin": -7.9, "roe_by_year": { "2023": 6.2195, "2024": 0.2553, "2025": -1.6417 }, "roe_avg": 1.61, "common_equity_yi": 196.9483, "pb": 0.26, "roe_pb": 6.11, "watched": false }, { "code": "00897", "name": "位元堂", "l1": "药品及生物科技", "l2": "非H股", "price": 0.375, "market_cap_yi": 3.6, "ev_yi": 6.4, "ee": 159, "loss": false, "ygc": 2.03, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 3.94, "cash_yi": 1.18, "np_ttm_yi": 0.04, "period": "2026-03-31", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 0.7, 1, 1.4, 0.7, 0.5 ], "fcf_avg_yi": 0.86, "ibd_yi": 2.47, "k": 1, "k_src": "equity", "iv_yi": 7.309999999999999 }, "revenue_ttm_yi": 6.03, "net_margin": 0.7, "roe_by_year": { "2023": -0.822, "2024": 0.553, "2025": 0.3379 }, "roe_avg": 0.02, "common_equity_yi": 10.4344, "pb": 0.35, "roe_pb": 0.07, "watched": false }, { "code": "06896", "name": "金嗓子", "l1": "药品及生物科技", "l2": "非H股", "price": 1.905, "market_cap_yi": 12, "ev_yi": 12.1, "ee": 5.6, "loss": false, "ygc": 1.98, "triggered": true, "fcf_growth": [ "trend" ], "detail": { "total_liabilities_yi": 9.35, "cash_yi": 9.23, "np_ttm_yi": 2.15, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 1.1, 2.6, 2.2, 4.1, 0.8 ], "fcf_avg_yi": 2.16, "ibd_yi": 7.11, "k": 1, "k_src": "profit", "iv_yi": 23.720000000000002 }, "revenue_ttm_yi": 9.04, "net_margin": 23.8, "roe_by_year": { "2023": 16.1927, "2024": 21.1224, "2025": 17.6716 }, "roe_avg": 18.33, "common_equity_yi": 11.9965, "pb": 1, "roe_pb": 18.32, "watched": false }, { "code": "01061", "name": "亿胜生物科技", "l1": "药品及生物科技", "l2": "非H股", "price": 2.085, "market_cap_yi": 10, "ev_yi": 12.3, "ee": 5.2, "loss": false, "ygc": 1.92, "triggered": true, "fcf_growth": [ "trend" ], "detail": { "total_liabilities_yi": 9.27, "cash_yi": 7.01, "np_ttm_yi": 2.34, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 1.3, 0.9, 1.9, 2.3, 1.2 ], "fcf_avg_yi": 1.52, "ibd_yi": 3.03, "k": 1, "k_src": "profit", "iv_yi": 19.18 }, "revenue_ttm_yi": 15.2, "net_margin": 15.4, "roe_by_year": { "2023": 15.0615, "2024": 15.1808, "2025": 14.0227 }, "roe_avg": 14.76, "common_equity_yi": 22.1416, "pb": 0.45, "roe_pb": 32.67, "watched": false }, { "code": "08049", "name": "吉林长龙药业", "l1": "药品及生物科技", "l2": "H股 · 创业板", "price": 2.48, "market_cap_yi": 11.8, "ev_yi": 21, "ee": 9.6, "loss": false, "ygc": 1.86, "triggered": true, "fcf_growth": [ "end", "trend" ], "detail": { "total_liabilities_yi": 9.23, "cash_yi": 0, "np_ttm_yi": 2.19, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 1.2, 1.9, 2.8, 2.1, 3 ], "fcf_avg_yi": 2.2, "ibd_yi": 0.01, "k": 1, "k_src": "profit", "iv_yi": 21.99 }, "revenue_ttm_yi": 8.98, "net_margin": 24.4, "roe_by_year": { "2023": 9.5844, "2024": 11.8489, "2025": 11.988 }, "roe_avg": 11.14, "common_equity_yi": 18.1127, "pb": 0.65, "roe_pb": 17.1, "watched": false }, { "code": "00239", "name": "白花油", "l1": "药品及生物科技", "l2": "非H股", "price": 2.39, "market_cap_yi": 6.3, "ev_yi": 4.4, "ee": 5, "loss": false, "ygc": 1.76, "triggered": true, "fcf_growth": [ "end", "trend" ], "detail": { "total_liabilities_yi": 1.25, "cash_yi": 3.19, "np_ttm_yi": 0.87, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 0.6, 0.4, 1.3, 0.7, 1 ], "fcf_avg_yi": 0.8, "ibd_yi": 0.12, "k": 1, "k_src": "profit", "iv_yi": 11.07 }, "revenue_ttm_yi": 1.95, "net_margin": 44.6, "roe_by_year": { "2023": 14.2676, "2024": 10.5042, "2025": 12.5591 }, "roe_avg": 12.44, "common_equity_yi": 6.3755, "pb": 0.99, "roe_pb": 12.59, "watched": false }, { "code": "01666", "name": "同仁堂科技", "l1": "药品及生物科技", "l2": "H股", "price": 3.105, "market_cap_yi": 33.9, "ev_yi": 25.1, "ee": 8.2, "loss": false, "ygc": 1.57, "triggered": true, "fcf_growth": [], "detail": { "total_liabilities_yi": 32.99, "cash_yi": 47.9, "np_ttm_yi": 3.07, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 8.6, 5.5, 4.5, -2, 14.3 ], "fcf_avg_yi": 6.180000000000001, "ibd_yi": 19.11, "k": 0.589, "k_src": "profit", "iv_yi": 53.35751 }, "revenue_ttm_yi": 57.7, "net_margin": 5.3, "roe_by_year": { "2023": 8.8271, "2024": 7.4037, "2025": 5.4484 }, "roe_avg": 7.23, "common_equity_yi": 73.043, "pb": 0.46, "roe_pb": 15.57, "watched": false }, { "code": "03737", "name": "中智药业", "l1": "药品及生物科技", "l2": "非H股", "price": 0.65, "market_cap_yi": 4.8, "ev_yi": 9.7, "ee": 53.8, "loss": false, "ygc": 1.56, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 6.55, "cash_yi": 1.62, "np_ttm_yi": 0.18, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 0.1, 2, -0.7, 0.5, 1.5 ], "fcf_avg_yi": 0.68, "ibd_yi": 0.88, "k": 0.992, "k_src": "profit", "iv_yi": 7.479680000000001 }, "revenue_ttm_yi": 16.47, "net_margin": 1.1, "roe_by_year": { "2023": 15.8689, "2024": 8.7954, "2025": 1.5638 }, "roe_avg": 8.74, "common_equity_yi": 11.0236, "pb": 0.44, "roe_pb": 20.08, "watched": false }, { "code": "02633", "name": "雅各臣科研制药", "l1": "药品及生物科技", "l2": "非H股", "price": 0.96, "market_cap_yi": 16.4, "ev_yi": 23.6, "ee": 8.9, "loss": false, "ygc": 1.5, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 10.8, "cash_yi": 3.27, "np_ttm_yi": 2.66, "period": "2026-03-31", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 2.8, 5, 3.2, 2.6, 1.7 ], "fcf_avg_yi": 3.0599999999999996, "ibd_yi": 8.04, "k": 0.952, "k_src": "profit", "iv_yi": 24.590159999999994 }, "revenue_ttm_yi": 13.86, "net_margin": 19.2, "roe_by_year": { "2023": 10.4512, "2024": 12.4688, "2025": 12.6485 }, "roe_avg": 11.86, "common_equity_yi": 20.4491, "pb": 0.8, "roe_pb": 14.78, "watched": false }, { "code": "03320", "name": "华润医药", "l1": "药品及生物科技", "l2": "红筹股", "price": 4.605, "market_cap_yi": 246.4, "ev_yi": 995.4, "ee": 24, "loss": false, "ygc": 1.41, "triggered": false, "fcf_growth": [ "end", "trend" ], "detail": { "total_liabilities_yi": 1749.92, "cash_yi": 156.22, "np_ttm_yi": 41.55, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 82.2, 80.8, 124.2, 143.3, 169.3 ], "fcf_avg_yi": 119.96, "ibd_yi": 617.64, "k": 0.47, "k_src": "profit", "iv_yi": 346.9446 }, "revenue_ttm_yi": 2721.65, "net_margin": 1.5, "roe_by_year": { "2023": 8.6112, "2024": 7.1141, "2025": 8.1191 }, "roe_avg": 7.95, "common_equity_yi": 527.9645, "pb": 0.47, "roe_pb": 17.03, "watched": false }, { "code": "09885", "name": "药师帮", "l1": "药品及生物科技", "l2": "非H股", "price": 3.395, "market_cap_yi": 20, "ev_yi": 62.5, "ee": 33.6, "loss": false, "ygc": 1.38, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 50.61, "cash_yi": 8.07, "np_ttm_yi": 1.86, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -6.1, 0.5, 4.3, 6.3, 6.2 ], "fcf_avg_yi": 2.2399999999999998, "ibd_yi": 2.96, "k": 1, "k_src": "equity", "iv_yi": 27.509999999999998 }, "revenue_ttm_yi": 214.1, "net_margin": 0.9, "roe_by_year": { "2023": 262.3766, "2024": 1.4161, "2025": 6.4239 }, "roe_avg": 90.07, "common_equity_yi": 23.8305, "pb": 0.84, "roe_pb": 107.32, "watched": false }, { "code": "03933", "name": "联邦制药", "l1": "药品及生物科技", "l2": "非H股", "price": 7.27, "market_cap_yi": 122, "ev_yi": 159.5, "ee": 29.6, "loss": false, "ygc": 1.32, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 148.17, "cash_yi": 110.69, "np_ttm_yi": 5.39, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 11.2, 12.1, 9.8, 13.3, 8.6 ], "fcf_avg_yi": 10.999999999999998, "ibd_yi": 59.48, "k": 1, "k_src": "profit", "iv_yi": 161.20999999999998 }, "revenue_ttm_yi": 118.58, "net_margin": 4.5, "roe_by_year": { "2023": 23.145, "2024": 19.6121, "2025": 13.1266 }, "roe_avg": 18.63, "common_equity_yi": 172.1647, "pb": 0.71, "roe_pb": 26.29, "watched": false }, { "code": "03613", "name": "同仁堂国药", "l1": "药品及生物科技", "l2": "红筹股", "price": 5.75, "market_cap_yi": 41, "ev_yi": 25.7, "ee": 8.1, "loss": false, "ygc": 1.29, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 2.37, "cash_yi": 18.75, "np_ttm_yi": 3.17, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 6.3, 4.5, 4, -2.4, 7.1 ], "fcf_avg_yi": 3.9, "ibd_yi": 1.09, "k": 0.935, "k_src": "profit", "iv_yi": 52.9771 }, "revenue_ttm_yi": 11.95, "net_margin": 26.5, "roe_by_year": { "2023": 14.4664, "2024": 12.5985, "2025": 9.614 }, "roe_avg": 12.23, "common_equity_yi": 35.2175, "pb": 1.16, "roe_pb": 10.5, "watched": false }, { "code": "01099", "name": "国药控股", "l1": "药品及生物科技", "l2": "H股", "price": 15.72, "market_cap_yi": 417.8, "ev_yi": 1889.8, "ee": 26.6, "loss": false, "ygc": 1.11, "triggered": false, "fcf_growth": [ "end", "trend" ], "detail": { "total_liabilities_yi": 2680.87, "cash_yi": 310.45, "np_ttm_yi": 70.93, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 70.5, 185.5, 148.4, 95.8, 125.2 ], "fcf_avg_yi": 125.08, "ibd_yi": 813.16, "k": 0.621, "k_src": "profit", "iv_yi": 464.56388999999996 }, "revenue_ttm_yi": 5719.24, "net_margin": 1.2, "roe_by_year": { "2023": 12.6936, "2024": 9.1873, "2025": 8.788 }, "roe_avg": 10.22, "common_equity_yi": 851.9406, "pb": 0.49, "roe_pb": 20.85, "watched": false }, { "code": "01530", "name": "三生制药", "l1": "药品及生物科技", "l2": "非H股", "price": 14.47, "market_cap_yi": 309.7, "ev_yi": 290.9, "ee": 3.5, "loss": false, "ygc": 1.05, "triggered": false, "fcf_growth": [ "end", "yoy", "trend" ], "detail": { "total_liabilities_yi": 48.14, "cash_yi": 67.85, "np_ttm_yi": 82.71, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 4.3, 11.6, 13.8, 22.4, 91.3 ], "fcf_avg_yi": 28.679999999999996, "ibd_yi": 13.87, "k": 0.955, "k_src": "profit", "iv_yi": 325.44489999999996 }, "revenue_ttm_yi": 178.66, "net_margin": 46.3, "roe_by_year": { "2023": 11.4931, "2024": 14.1861, "2025": 39.781 }, "roe_avg": 21.82, "common_equity_yi": 275.191, "pb": 1.13, "roe_pb": 19.39, "watched": false }, { "code": "01513", "name": "丽珠医药", "l1": "药品及生物科技", "l2": "H股", "price": 21.26, "market_cap_yi": 218.7, "ev_yi": 233.9, "ee": 14, "loss": false, "ygc": 1, "triggered": false, "fcf_growth": [ "end", "trend" ], "detail": { "total_liabilities_yi": 89.94, "cash_yi": 73.51, "np_ttm_yi": 16.74, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 5.9, 18.3, 24.3, 24.1, 25.7 ], "fcf_avg_yi": 19.66, "ibd_yi": 34.4, "k": 0.924, "k_src": "profit", "iv_yi": 217.79604 }, "revenue_ttm_yi": 107.48, "net_margin": 15.6, "roe_by_year": { "2023": 13.9954, "2024": 14.7723, "2025": 14.5816 }, "roe_avg": 14.45, "common_equity_yi": 133.6583, "pb": 1.64, "roe_pb": 8.83, "watched": false }, { "code": "00690", "name": "联康生物科技集团", "l1": "药品及生物科技", "l2": "非H股", "price": 0.067, "market_cap_yi": 3.4, "ev_yi": 3.4, "ee": 8, "loss": false, "ygc": 0.89, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 1.36, "cash_yi": 1.38, "np_ttm_yi": 0.42, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 0, 0.2, 0.4, 0.3, 0.3 ], "fcf_avg_yi": 0.24000000000000005, "ibd_yi": 0.74, "k": 1, "k_src": "equity", "iv_yi": 3.04 }, "revenue_ttm_yi": 4.84, "net_margin": 8.7, "roe_by_year": { "2023": 31.3666, "2024": 28.4047, "2025": 25.2613 }, "roe_avg": 28.34, "common_equity_yi": 3.8973, "pb": 0.87, "roe_pb": 32.49, "watched": false }, { "code": "00867", "name": "康哲药业", "l1": "药品及生物科技", "l2": "非H股", "price": 10.2, "market_cap_yi": 211.4, "ev_yi": 201.6, "ee": 13.1, "loss": false, "ygc": 0.89, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 15.93, "cash_yi": 25.72, "np_ttm_yi": 15.34, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 23.1, 30.3, 21.8, 8.1, 2.4 ], "fcf_avg_yi": 17.14, "ibd_yi": 8.83, "k": 1, "k_src": "profit", "iv_yi": 188.29 }, "revenue_ttm_yi": 87.11, "net_margin": 17.6, "roe_by_year": { "2023": 15.9482, "2024": 10.1772, "2025": 8.8343 }, "roe_avg": 11.65, "common_equity_yi": 179.4692, "pb": 1.18, "roe_pb": 9.89, "watched": false }, { "code": "01681", "name": "康臣药业", "l1": "药品及生物科技", "l2": "非H股", "price": 15.68, "market_cap_yi": 111.9, "ev_yi": 116.9, "ee": 9.9, "loss": false, "ygc": 0.88, "triggered": false, "fcf_growth": [ "end", "trend" ], "detail": { "total_liabilities_yi": 17.7, "cash_yi": 12.69, "np_ttm_yi": 11.75, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 6.3, 9, 7.7, 9.8, 11.4 ], "fcf_avg_yi": 8.84, "ibd_yi": 2.29, "k": 0.996, "k_src": "profit", "iv_yi": 98.4048 }, "revenue_ttm_yi": 36.33, "net_margin": 32.3, "roe_by_year": { "2023": 23.1712, "2024": 23.5745, "2025": 24.9765 }, "roe_avg": 23.91, "common_equity_yi": 47.6094, "pb": 2.35, "roe_pb": 10.17, "watched": false }, { "code": "02161", "name": "健倍苗苗", "l1": "药品及生物科技", "l2": "非H股", "price": 1.6, "market_cap_yi": 11.2, "ev_yi": 15.5, "ee": 8.7, "loss": false, "ygc": 0.85, "triggered": false, "fcf_growth": [ "end", "trend" ], "detail": { "total_liabilities_yi": 5.58, "cash_yi": 1.06, "np_ttm_yi": 1.78, "period": "2026-03-31", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 0.4, 1.2, 1.6, 1.9, 1.1 ], "fcf_avg_yi": 1.2399999999999998, "ibd_yi": 3.48, "k": 0.959, "k_src": "profit", "iv_yi": 9.570819999999998 }, "revenue_ttm_yi": 7.37, "net_margin": 24.2, "roe_by_year": { "2023": 13.3385, "2024": 19.2197, "2025": 18.6008 }, "roe_avg": 17.05, "common_equity_yi": 9.537, "pb": 1.17, "roe_pb": 14.52, "watched": false }, { "code": "01643", "name": "现代中药集团", "l1": "药品及生物科技", "l2": "非H股", "price": 0.365, "market_cap_yi": 2.2, "ev_yi": 1.3, "ee": null, "loss": true, "ygc": 0.72, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 0.31, "cash_yi": 1.2, "np_ttm_yi": -0.42, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -0.1, 1.1, 0, -0.6, -0.2 ], "fcf_avg_yi": 0.04, "ibd_yi": 0.01, "k": 1, "k_src": "equity", "iv_yi": 1.5899999999999999 }, "revenue_ttm_yi": 1.99, "net_margin": -21.1, "roe_by_year": { "2023": 10.8939, "2024": 2.0207, "2025": -2.7605 }, "roe_avg": 3.38, "common_equity_yi": 4.684, "pb": 0.47, "roe_pb": 7.21, "watched": false }, { "code": "06618", "name": "京东健康", "l1": "药品及生物科技", "l2": "非H股", "price": 38.56, "market_cap_yi": 1047.8, "ev_yi": 1070.5, "ee": 17.2, "loss": false, "ygc": 0.68, "triggered": false, "fcf_growth": [ "end", "trend" ], "detail": { "total_liabilities_yi": 227.15, "cash_yi": 204.46, "np_ttm_yi": 62.16, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 29.1, 36.3, 45.4, 43.3, 101.7 ], "fcf_avg_yi": 51.160000000000004, "ibd_yi": 8.75, "k": 1, "k_src": "equity", "iv_yi": 707.3100000000001 }, "revenue_ttm_yi": 790.39, "net_margin": 7.9, "roe_by_year": { "2023": 4.5505, "2024": 7.9586, "2025": 9.324 }, "roe_avg": 7.28, "common_equity_yi": 614.5611, "pb": 1.7, "roe_pb": 4.27, "watched": false }, { "code": "00874", "name": "白云山", "l1": "药品及生物科技", "l2": "H股", "price": 13.3, "market_cap_yi": 305.2, "ev_yi": 631.4, "ee": 24.6, "loss": false, "ygc": 0.66, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 463.37, "cash_yi": 118.88, "np_ttm_yi": 25.63, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 44.2, 56.2, 24.8, 23.1, -14.7 ], "fcf_avg_yi": 26.720000000000006, "ibd_yi": 174.54, "k": 0.947, "k_src": "profit", "iv_yi": 200.32838000000004 }, "revenue_ttm_yi": 779.13, "net_margin": 3.3, "roe_by_year": { "2023": 12.1093, "2024": 8.0072, "2025": 8.0961 }, "roe_avg": 9.4, "common_equity_yi": 391.3205, "pb": 0.78, "roe_pb": 12.06, "watched": false }, { "code": "01498", "name": "培力农本方", "l1": "药品及生物科技", "l2": "非H股", "price": 0.241, "market_cap_yi": 1.1, "ev_yi": 6, "ee": null, "loss": true, "ygc": 0.63, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 4.99, "cash_yi": 0.11, "np_ttm_yi": -0.24, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -0.2, 0.6, 0.5, 0.8, 0.2 ], "fcf_avg_yi": 0.38, "ibd_yi": 3.22, "k": 1, "k_src": "equity", "iv_yi": 0.6899999999999996 }, "revenue_ttm_yi": 2.85, "net_margin": -8.4, "roe_by_year": { "2023": -51.5551, "2024": -26.8037, "2025": -29.1482 }, "roe_avg": -35.84, "common_equity_yi": 1.0853, "pb": 1.01, "roe_pb": -35.36, "watched": false }, { "code": "03880", "name": "泰德医药", "l1": "药品及生物科技", "l2": "H股", "price": 20.4, "market_cap_yi": 24.6, "ev_yi": 19, "ee": 11.2, "loss": false, "ygc": 0.63, "triggered": false, "fcf_growth": [ "end", "trend" ], "detail": { "total_liabilities_yi": 2.29, "cash_yi": 7.88, "np_ttm_yi": 1.69, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 0.9, 0.4, 0.3, 1, 1.4 ], "fcf_avg_yi": 0.8, "ibd_yi": 0.31, "k": 1, "k_src": "profit", "iv_yi": 15.57 }, "revenue_ttm_yi": 5.51, "net_margin": 30.7, "roe_by_year": { "2023": 21.4331, "2024": 20.667, "2025": 22.8386 }, "roe_avg": 21.65, "common_equity_yi": 16.3632, "pb": 1.5, "roe_pb": 14.4, "watched": false }, { "code": "06667", "name": "美因基因", "l1": "药品及生物科技", "l2": "非H股", "price": 7.19, "market_cap_yi": 13.5, "ev_yi": 11.5, "ee": 46, "loss": false, "ygc": 0.57, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 2.24, "cash_yi": 4.25, "np_ttm_yi": 0.25, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 0.3, -0.1, 1.3, 0.6, -0.2 ], "fcf_avg_yi": 0.38, "ibd_yi": 0.29, "k": 1, "k_src": "equity", "iv_yi": 7.76 }, "revenue_ttm_yi": 3.58, "net_margin": 7, "roe_by_year": { "2023": 4.7573, "2024": 7.1528, "2025": 4.4094 }, "roe_avg": 5.44, "common_equity_yi": 6.0555, "pb": 2.23, "roe_pb": 2.44, "watched": false }, { "code": "02566", "name": "九源基因", "l1": "药品及生物科技", "l2": "H股", "price": 5.23, "market_cap_yi": 10.6, "ev_yi": 12, "ee": 8.5, "loss": false, "ygc": 0.53, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 4.68, "cash_yi": 3.31, "np_ttm_yi": 1.4, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 0, -0.4, 0.9, 0.1, 1.5 ], "fcf_avg_yi": 0.42000000000000004, "ibd_yi": 1.9, "k": 1, "k_src": "profit", "iv_yi": 5.61 }, "revenue_ttm_yi": 12.98, "net_margin": 10.8, "roe_by_year": { "2023": 14.3954, "2024": 11.4741, "2025": 8.7427 }, "roe_avg": 11.54, "common_equity_yi": 16.8702, "pb": 0.63, "roe_pb": 18.36, "watched": false }, { "code": "08225", "name": "中国医疗集团", "l1": "药品及生物科技", "l2": "非H股 · 创业板", "price": 0.078, "market_cap_yi": 0.7, "ev_yi": 0.7, "ee": null, "loss": true, "ygc": 0.49, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 0.35, "cash_yi": 0.34, "np_ttm_yi": -0.14, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -0.1, -0.1, 0, 0.1, 0.1 ], "fcf_avg_yi": 0, "ibd_yi": 0, "k": 1, "k_src": "equity", "iv_yi": 0.34 }, "revenue_ttm_yi": 0.3, "net_margin": -46.7, "roe_by_year": { "2023": -51.0819, "2024": -18.7134, "2025": -23.7976 }, "roe_avg": -31.2, "common_equity_yi": 0.6489, "pb": 1.08, "roe_pb": -28.92, "watched": false }, { "code": "01093", "name": "石药集团", "l1": "药品及生物科技", "l2": "非H股", "price": 8.88, "market_cap_yi": 871.5, "ev_yi": 939.6, "ee": 12.6, "loss": false, "ygc": 0.45, "triggered": false, "fcf_growth": [ "end" ], "detail": { "total_liabilities_yi": 165.9, "cash_yi": 96.66, "np_ttm_yi": 74.28, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 28.8, 49, 22.9, 18.6, 35.5 ], "fcf_avg_yi": 30.959999999999997, "ibd_yi": 6.52, "k": 0.984, "k_src": "profit", "iv_yi": 393.34416 }, "revenue_ttm_yi": 313.27, "net_margin": 23.7, "roe_by_year": { "2023": 18.5276, "2024": 13.2219, "2025": 11.8641 }, "roe_avg": 14.54, "common_equity_yi": 376.2411, "pb": 2.32, "roe_pb": 6.28, "watched": false }, { "code": "00512", "name": "远大医药", "l1": "药品及生物科技", "l2": "非H股", "price": 4.59, "market_cap_yi": 138.8, "ev_yi": 226.4, "ee": 23.7, "loss": false, "ygc": 0.43, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 93.38, "cash_yi": 5.41, "np_ttm_yi": 9.55, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 12, 6.8, 17.5, 11.8, 1.2 ], "fcf_avg_yi": 9.86, "ibd_yi": 43.87, "k": 0.996, "k_src": "profit", "iv_yi": 59.89944 }, "revenue_ttm_yi": 109.99, "net_margin": 8.7, "roe_by_year": { "2023": 12.8336, "2024": 15.6074, "2025": 7.4103 }, "roe_avg": 11.95, "common_equity_yi": 149.9068, "pb": 0.93, "roe_pb": 12.91, "watched": false }, { "code": "01177", "name": "中国生物制药", "l1": "药品及生物科技", "l2": "非H股", "price": 5.25, "market_cap_yi": 835.4, "ev_yi": 999.3, "ee": 41.8, "loss": false, "ygc": 0.36, "triggered": false, "fcf_growth": [ "end", "trend" ], "detail": { "total_liabilities_yi": 369.63, "cash_yi": 121.24, "np_ttm_yi": 23.89, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 35, 47.2, 45.9, 52.2, 75.9 ], "fcf_avg_yi": 51.24000000000001, "ibd_yi": 171.71, "k": 0.66, "k_src": "profit", "iv_yi": 304.8738000000001 }, "revenue_ttm_yi": 337.04, "net_margin": 7.1, "roe_by_year": { "2023": 7.7445, "2024": 11.2111, "2025": 7.4829 }, "roe_avg": 8.81, "common_equity_yi": 325.6808, "pb": 2.57, "roe_pb": 3.44, "watched": false }, { "code": "01345", "name": "上海先锋控股", "l1": "药品及生物科技", "l2": "非H股", "price": 2.07, "market_cap_yi": 22.2, "ev_yi": 26.4, "ee": 21.4, "loss": false, "ygc": 0.35, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 5.73, "cash_yi": 1.57, "np_ttm_yi": 1.23, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 2.2, 0.2, -1.6, 1.6, 1.8 ], "fcf_avg_yi": 0.8400000000000001, "ibd_yi": 2.18, "k": 1, "k_src": "equity", "iv_yi": 7.790000000000001 }, "revenue_ttm_yi": 12.39, "net_margin": 9.9, "roe_by_year": { "2023": 14.4687, "2024": 14.3246, "2025": 10.5918 }, "roe_avg": 13.13, "common_equity_yi": 10.3992, "pb": 2.13, "roe_pb": 6.15, "watched": false }, { "code": "00241", "name": "阿里健康", "l1": "药品及生物科技", "l2": "非H股", "price": 3.005, "market_cap_yi": 414, "ev_yi": 412, "ee": 21.3, "loss": false, "ygc": 0.34, "triggered": false, "fcf_growth": [ "end", "trend" ], "detail": { "total_liabilities_yi": 52.37, "cash_yi": 54.34, "np_ttm_yi": 19.36, "period": "2026-03-31", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 4.1, 2.5, 10.6, 13.8, 12.3 ], "fcf_avg_yi": 8.66, "ibd_yi": 0.6, "k": 1, "k_src": "equity", "iv_yi": 140.34 }, "revenue_ttm_yi": 342.55, "net_margin": 5.7, "roe_by_year": { "2023": 5.9458, "2024": 9.2845, "2025": 11.3333 }, "roe_avg": 8.85, "common_equity_yi": 178.554, "pb": 2.32, "roe_pb": 3.82, "watched": false }, { "code": "01110", "name": "金活医药集团", "l1": "药品及生物科技", "l2": "非H股", "price": 0.37, "market_cap_yi": 2, "ev_yi": 4.5, "ee": 41, "loss": false, "ygc": 0.32, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 6.49, "cash_yi": 1.79, "np_ttm_yi": 0.11, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 0.2, 0.9, -0.6, 0.9, 0.5 ], "fcf_avg_yi": 0.38, "ibd_yi": 4.38, "k": 0.534, "k_src": "profit", "iv_yi": 0.64614 }, "revenue_ttm_yi": 7.88, "net_margin": 1.4, "roe_by_year": { "2023": 6.1713, "2024": 6.6025, "2025": 1.7944 }, "roe_avg": 4.86, "common_equity_yi": 5.9656, "pb": 0.34, "roe_pb": 14.48, "watched": false }, { "code": "06915", "name": "江西生物", "l1": "药品及生物科技", "l2": "H股", "price": 7.695, "market_cap_yi": 20.2, "ev_yi": 16.7, "ee": 23.2, "loss": false, "ygc": 0.31, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 0.56, "cash_yi": 4.08, "np_ttm_yi": 0.72, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ null, -0.3, 0.3, 0.7, 0.2 ], "fcf_avg_yi": 0.22499999999999998, "ibd_yi": 0.01, "k": 1, "k_src": "profit", "iv_yi": 6.32 }, "revenue_ttm_yi": 2.19, "net_margin": 32.9, "roe_by_year": { "2023": 14.7089, "2024": 19.6403, "2025": 21.0363 }, "roe_avg": 18.46, "common_equity_yi": 8.4268, "pb": 2.4, "roe_pb": 7.7, "watched": false }, { "code": "09606", "name": "映恩生物-B", "l1": "药品及生物科技", "l2": "非H股", "price": 170, "market_cap_yi": 132.3, "ev_yi": 130.2, "ee": null, "loss": true, "ygc": 0.31, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 20.56, "cash_yi": 22.65, "np_ttm_yi": -14.39, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ null, -3.2, 7.8, 2.5, 1.8 ], "fcf_avg_yi": 2.225, "ibd_yi": 3.79, "k": 1, "k_src": "equity", "iv_yi": 41.11 }, "revenue_ttm_yi": 8.42, "net_margin": -170.9, "roe_by_year": { "2023": 37.7714, "2024": 66.783, "2025": -1282.14 }, "roe_avg": -392.53, "common_equity_yi": 14.5072, "pb": 9.12, "roe_pb": -43.04, "watched": false }, { "code": "00719", "name": "山东新华制药股份", "l1": "药品及生物科技", "l2": "H股", "price": 5.495, "market_cap_yi": 77.9, "ev_yi": 99, "ee": 46, "loss": false, "ygc": 0.3, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 35.75, "cash_yi": 13.9, "np_ttm_yi": 2.15, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 0.1, 5.1, -0.6, 1.6, 4.2 ], "fcf_avg_yi": 2.0799999999999996, "ibd_yi": 10.79, "k": 0.966, "k_src": "profit", "iv_yi": 23.097059999999995 }, "revenue_ttm_yi": 84.73, "net_margin": 2.5, "roe_by_year": { "2023": 11.4412, "2024": 9.8489, "2025": 5.6839 }, "roe_avg": 8.99, "common_equity_yi": 52.7125, "pb": 1.48, "roe_pb": 6.08, "watched": false }, { "code": "01349", "name": "复旦张江", "l1": "药品及生物科技", "l2": "H股", "price": 2.455, "market_cap_yi": 60.1, "ev_yi": 50.5, "ee": null, "loss": true, "ygc": 0.29, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 2.6, "cash_yi": 12.23, "np_ttm_yi": -1.26, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 1.5, 0.8, -0.3, -0.6, 1.1 ], "fcf_avg_yi": 0.5, "ibd_yi": 0.07, "k": 1, "k_src": "equity", "iv_yi": 17.16 }, "revenue_ttm_yi": 6.68, "net_margin": -18.9, "roe_by_year": { "2023": 4.7079, "2024": 1.7045, "2025": -7.1226 }, "roe_avg": -0.24, "common_equity_yi": 21.5268, "pb": 2.79, "roe_pb": -0.08, "watched": false }, { "code": "01276", "name": "恒瑞医药", "l1": "药品及生物科技", "l2": "H股", "price": 47.6, "market_cap_yi": 3079.2, "ev_yi": 2756.7, "ee": 35.7, "loss": false, "ygc": 0.28, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 57.83, "cash_yi": 380.32, "np_ttm_yi": 77.26, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ null, -7.3, 61.6, 54.5, 82.7 ], "fcf_avg_yi": 47.875, "ibd_yi": 0.68, "k": 1, "k_src": "profit", "iv_yi": 858.39 }, "revenue_ttm_yi": 313.24, "net_margin": 24.7, "roe_by_year": { "2023": 10.9911, "2024": 14.7386, "2025": 14.4413 }, "roe_avg": 13.39, "common_equity_yi": 644.6643, "pb": 4.78, "roe_pb": 2.8, "watched": false }, { "code": "09989", "name": "海普瑞", "l1": "药品及生物科技", "l2": "H股", "price": 3.96, "market_cap_yi": 123.7, "ev_yi": 153.3, "ee": 75.5, "loss": false, "ygc": 0.25, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 43.25, "cash_yi": 13.52, "np_ttm_yi": 2.03, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -2.4, -9.8, -0.5, 19.9, 15.9 ], "fcf_avg_yi": 4.619999999999999, "ibd_yi": 28.95, "k": 0.996, "k_src": "equity", "iv_yi": 30.646919999999987 }, "revenue_ttm_yi": 52.1, "net_margin": 3.9, "roe_by_year": { "2023": -6.4663, "2024": 5.3757, "2025": 2.8907 }, "roe_avg": 0.6, "common_equity_yi": 119.3384, "pb": 1.04, "roe_pb": 0.58, "watched": false }, { "code": "03692", "name": "翰森制药", "l1": "药品及生物科技", "l2": "非H股", "price": 31.74, "market_cap_yi": 1639.3, "ev_yi": 1681.1, "ee": 25.2, "loss": false, "ygc": 0.21, "triggered": false, "fcf_growth": [ "end", "yoy", "trend" ], "detail": { "total_liabilities_yi": 88.37, "cash_yi": 46.57, "np_ttm_yi": 66.78, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 21, 24.5, 27.5, 33.4, 62.5 ], "fcf_avg_yi": 33.78, "ibd_yi": 42.34, "k": 1, "k_src": "profit", "iv_yi": 342.03000000000003 }, "revenue_ttm_yi": 158.99, "net_margin": 42, "roe_by_year": { "2023": 13.5317, "2024": 16.0508, "2025": 17.3488 }, "roe_avg": 15.64, "common_equity_yi": 377.6807, "pb": 4.34, "roe_pb": 3.6, "watched": false }, { "code": "02096", "name": "先声药业", "l1": "药品及生物科技", "l2": "非H股", "price": 11.02, "market_cap_yi": 241, "ev_yi": 270, "ee": 17.2, "loss": false, "ygc": 0.18, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 59.74, "cash_yi": 30.72, "np_ttm_yi": 15.72, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -4.1, 6.8, -8.3, 6.2, 11.5 ], "fcf_avg_yi": 2.42, "ibd_yi": 11.72, "k": 1, "k_src": "profit", "iv_yi": 43.199999999999996 }, "revenue_ttm_yi": 87.27, "net_margin": 18, "roe_by_year": { "2023": 9.9587, "2024": 10.2606, "2025": 16.2499 }, "roe_avg": 12.16, "common_equity_yi": 94.2425, "pb": 2.56, "roe_pb": 4.75, "watched": false }, { "code": "02552", "name": "华领医药-B", "l1": "药品及生物科技", "l2": "非H股", "price": 2.09, "market_cap_yi": 18.8, "ev_yi": 13.3, "ee": null, "loss": true, "ygc": 0.17, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 5.22, "cash_yi": 10.73, "np_ttm_yi": -1.08, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -3.4, -2.6, 8.8, -4.2, -0.6 ], "fcf_avg_yi": -0.3999999999999999, "ibd_yi": 3.54, "k": 1, "k_src": "equity", "iv_yi": 3.1900000000000013 }, "revenue_ttm_yi": 6.54, "net_margin": -16.5, "roe_by_year": { "2023": -110.9623, "2024": 1457.928, "2025": 254.0458 }, "roe_avg": 533.67, "common_equity_yi": 9.9268, "pb": 1.89, "roe_pb": 281.79, "watched": false }, { "code": "03347", "name": "泰格医药", "l1": "药品及生物科技", "l2": "H股", "price": 40.2, "market_cap_yi": 411.6, "ev_yi": 436.5, "ee": 479.7, "loss": false, "ygc": 0.17, "triggered": false, "fcf_growth": [ "end", "trend" ], "detail": { "total_liabilities_yi": 48.02, "cash_yi": 20.43, "np_ttm_yi": 0.91, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 7.9, 6.8, 8.4, 7.4, 9 ], "fcf_avg_yi": 7.9, "ibd_yi": 20.91, "k": 0.904, "k_src": "profit", "iv_yi": 70.98208000000001 }, "revenue_ttm_yi": 72.9, "net_margin": 1.2, "roe_by_year": { "2023": 9.9589, "2024": 1.9433, "2025": 4.2656 }, "roe_avg": 5.39, "common_equity_yi": 194.7722, "pb": 2.11, "roe_pb": 2.55, "watched": false }, { "code": "01873", "name": "维亚生物", "l1": "药品及生物科技", "l2": "非H股", "price": 1.37, "market_cap_yi": 24.4, "ev_yi": 43.5, "ee": 24.5, "loss": false, "ygc": 0.16, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 29.21, "cash_yi": 10.04, "np_ttm_yi": 1.78, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -4.9, 1.4, 2, 1.8, 1.1 ], "fcf_avg_yi": 0.2799999999999999, "ibd_yi": 8.98, "k": 0.998, "k_src": "equity", "iv_yi": 3.8522799999999977 }, "revenue_ttm_yi": 19.04, "net_margin": 9.3, "roe_by_year": { "2023": -3.1844, "2024": 4.467, "2025": 5.6357 }, "roe_avg": 2.31, "common_equity_yi": 39.6229, "pb": 0.62, "roe_pb": 3.74, "watched": false }, { "code": "02637", "name": "海西新药", "l1": "药品及生物科技", "l2": "H股", "price": 161.8, "market_cap_yi": 108.5, "ev_yi": 101.3, "ee": 67.5, "loss": false, "ygc": 0.14, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 2.97, "cash_yi": 10.19, "np_ttm_yi": 1.5, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ null, 0.5, 0.9, -0.1, 1.1 ], "fcf_avg_yi": 0.6, "ibd_yi": 0.81, "k": 1, "k_src": "profit", "iv_yi": 15.379999999999999 }, "revenue_ttm_yi": 5.94, "net_margin": 25.3, "roe_by_year": { "2023": 33.8959, "2024": 28.7519, "2025": 16.583 }, "roe_avg": 26.41, "common_equity_yi": 16.6924, "pb": 6.5, "roe_pb": 4.06, "watched": false }, { "code": "06821", "name": "凯莱英", "l1": "药品及生物科技", "l2": "H股", "price": 137.6, "market_cap_yi": 530.8, "ev_yi": 524.7, "ee": 50.6, "loss": false, "ygc": 0.14, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 30.86, "cash_yi": 37, "np_ttm_yi": 10.36, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -15.5, 11.4, 23.1, 1.2, 1.4 ], "fcf_avg_yi": 4.319999999999999, "ibd_yi": 3.47, "k": 1, "k_src": "profit", "iv_yi": 76.72999999999999 }, "revenue_ttm_yi": 70.89, "net_margin": 14.6, "roe_by_year": { "2023": 13.6976, "2024": 5.5292, "2025": 6.5693 }, "roe_avg": 8.6, "common_equity_yi": 177.3987, "pb": 2.99, "roe_pb": 2.87, "watched": false }, { "code": "02359", "name": "药明康德", "l1": "药品及生物科技", "l2": "H股", "price": 196.2, "market_cap_yi": 4473.8, "ev_yi": 4527.5, "ee": 20.6, "loss": false, "ygc": 0.13, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 323.79, "cash_yi": 269.54, "np_ttm_yi": 219.88, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -32.6, 2.7, 71.3, 79.9, 108.9 ], "fcf_avg_yi": 46.04, "ibd_yi": 151.12, "k": 0.99, "k_src": "profit", "iv_yi": 573.0318 }, "revenue_ttm_yi": 527.93, "net_margin": 41.6, "roe_by_year": { "2023": 21.0204, "2024": 16.4434, "2025": 27.7494 }, "roe_avg": 21.74, "common_equity_yi": 833.3372, "pb": 5.37, "roe_pb": 4.05, "watched": false }, { "code": "06132", "name": "华健未来-B", "l1": "药品及生物科技", "l2": "H股", "price": 35.16, "market_cap_yi": 22, "ev_yi": 11.9, "ee": null, "loss": true, "ygc": 0.11, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 1.01, "cash_yi": 11.07, "np_ttm_yi": -1.56, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ null, null, null, -0.8, -0.9 ], "fcf_avg_yi": -0.8500000000000001, "ibd_yi": 0.22, "k": 1, "k_src": "equity", "iv_yi": 2.3499999999999996 }, "revenue_ttm_yi": 0.14, "net_margin": -1114.3, "roe_by_year": { "2024": -53.7741, "2025": -37.9218 }, "roe_avg": -45.85, "common_equity_yi": 12.0884, "pb": 1.82, "roe_pb": -25.19, "watched": false }, { "code": "02607", "name": "上海医药", "l1": "药品及生物科技", "l2": "H股", "price": 11.17, "market_cap_yi": 550.7, "ev_yi": 1467, "ee": 30.8, "loss": false, "ygc": 0.09, "triggered": false, "fcf_growth": [ "end", "yoy", "trend" ], "detail": { "total_liabilities_yi": 1479.84, "cash_yi": 322.84, "np_ttm_yi": 47.7, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 9.4, 20.6, 22.6, 34.3, 38.3 ], "fcf_avg_yi": 25.04, "ibd_yi": 512.79, "k": 0.792, "k_src": "profit", "iv_yi": 47.8764 }, "revenue_ttm_yi": 2894.57, "net_margin": 1.6, "roe_by_year": { "2023": 5.558, "2024": 6.4943, "2025": 7.7586 }, "roe_avg": 6.6, "common_equity_yi": 783.4796, "pb": 0.7, "roe_pb": 9.39, "watched": false }, { "code": "07630", "name": "英派药业-B", "l1": "药品及生物科技", "l2": "H股", "price": 13.02, "market_cap_yi": 31.3, "ev_yi": 26.9, "ee": null, "loss": true, "ygc": 0.09, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 3.79, "cash_yi": 8.21, "np_ttm_yi": -2.58, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ null, null, 0.2, -0.8, -1 ], "fcf_avg_yi": -0.5333333333333333, "ibd_yi": 0.04, "k": 1, "k_src": "equity", "iv_yi": 2.836666666666668 }, "revenue_ttm_yi": 1.18, "net_margin": -218.6, "roe_by_year": { "2023": -3.8516, "2024": 60.6791, "2025": 34.77 }, "roe_avg": 30.53, "common_equity_yi": 7.7577, "pb": 4.03, "roe_pb": 7.57, "watched": false }, { "code": "08622", "name": "愉悦集团", "l1": "药品及生物科技", "l2": "非H股 · 创业板", "price": 0.178, "market_cap_yi": 0.8, "ev_yi": 0.6, "ee": null, "loss": true, "ygc": 0.07, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 0.17, "cash_yi": 0.34, "np_ttm_yi": -0.05, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 0, 0, 0, -0.1, 0 ], "fcf_avg_yi": -0.02, "ibd_yi": 0.08, "k": 0.999, "k_src": "equity", "iv_yi": 0.05994 }, "revenue_ttm_yi": 0.33, "net_margin": -15.2, "roe_by_year": { "2023": -10.7529, "2024": -7.9149, "2025": -9.519 }, "roe_avg": -9.4, "common_equity_yi": 0.4908, "pb": 1.63, "roe_pb": -5.76, "watched": false }, { "code": "00460", "name": "四环医药", "l1": "药品及生物科技", "l2": "非H股", "price": 0.705, "market_cap_yi": 54.7, "ev_yi": 68.9, "ee": 22.8, "loss": false, "ygc": 0.06, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 46.74, "cash_yi": 30.63, "np_ttm_yi": 3.02, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -1, -5.5, -1, 0.9, -2.2 ], "fcf_avg_yi": -1.7600000000000002, "ibd_yi": 9.06, "k": 0.883, "k_src": "equity", "iv_yi": 3.5055099999999957 }, "revenue_ttm_yi": 26.33, "net_margin": 11.5, "roe_by_year": { "2023": -1.1782, "2024": -4.9217, "2025": 3.516 }, "roe_avg": -0.86, "common_equity_yi": 61.4925, "pb": 0.89, "roe_pb": -0.97, "watched": false }, { "code": "01521", "name": "方达控股", "l1": "药品及生物科技", "l2": "非H股", "price": 1.14, "market_cap_yi": 19.8, "ev_yi": 32.7, "ee": 44.7, "loss": false, "ygc": 0.04, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 15.27, "cash_yi": 2.35, "np_ttm_yi": 0.73, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -0.4, 1, 1.3, 1.1, 2.3 ], "fcf_avg_yi": 1.06, "ibd_yi": 12.17, "k": 0.995, "k_src": "profit", "iv_yi": 0.7761000000000016 }, "revenue_ttm_yi": 19.07, "net_margin": 3.8, "roe_by_year": { "2023": 3.1996, "2024": 0.2342, "2025": 1.9986 }, "roe_avg": 1.81, "common_equity_yi": 24.1714, "pb": 0.82, "roe_pb": 2.21, "watched": false }, { "code": "02269", "name": "药明生物", "l1": "药品及生物科技", "l2": "非H股", "price": 48.2, "market_cap_yi": 1690, "ev_yi": 1707.3, "ee": 34.1, "loss": false, "ygc": 0.04, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 108.42, "cash_yi": 89.5, "np_ttm_yi": 50.09, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -30.9, -3.3, 4.4, 12.9, 26.1 ], "fcf_avg_yi": 1.8400000000000005, "ibd_yi": 27.26, "k": 0.914, "k_src": "profit", "iv_yi": 73.70496 }, "revenue_ttm_yi": 236.24, "net_margin": 21.2, "roe_by_year": { "2023": 9.0204, "2024": 8.1705, "2025": 11.0216 }, "roe_avg": 9.4, "common_equity_yi": 480.7044, "pb": 3.52, "roe_pb": 2.67, "watched": false }, { "code": "01801", "name": "信达生物", "l1": "药品及生物科技", "l2": "非H股", "price": 89.05, "market_cap_yi": 1324.9, "ev_yi": 1488.4, "ee": 120.8, "loss": false, "ygc": 0.02, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 208.71, "cash_yi": 45.24, "np_ttm_yi": 12.32, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -38.7, -33, -12.4, -4.2, 93.2 ], "fcf_avg_yi": 0.9799999999999983, "ibd_yi": 23.23, "k": 1, "k_src": "equity", "iv_yi": 31.809999999999985 }, "revenue_ttm_yi": 157.06, "net_margin": 7.8, "roe_by_year": { "2023": -8.8394, "2024": -0.738, "2025": 5.0106 }, "roe_avg": -1.52, "common_equity_yi": 207.4584, "pb": 6.39, "roe_pb": -0.24, "watched": false }, { "code": "06086", "name": "方舟健客", "l1": "药品及生物科技", "l2": "非H股", "price": 0.82, "market_cap_yi": 9.7, "ev_yi": 12.9, "ee": 161, "loss": false, "ygc": 0.02, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 6.77, "cash_yi": 3.59, "np_ttm_yi": 0.08, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -2.1, -0.6, 0.2, 0.2, 0.7 ], "fcf_avg_yi": -0.31999999999999995, "ibd_yi": 0.23, "k": 1, "k_src": "equity", "iv_yi": 0.1600000000000006 }, "revenue_ttm_yi": 38.57, "net_margin": 0.2, "roe_by_year": { "2023": 10.8982, "2024": 96.6103, "2025": 8.2906 }, "roe_avg": 38.6, "common_equity_yi": 2.9646, "pb": 3.27, "roe_pb": 11.8, "watched": false }, { "code": "07666", "name": "剂泰科技-P", "l1": "药品及生物科技", "l2": "H股", "price": 11.92, "market_cap_yi": 120.1, "ev_yi": 97.8, "ee": null, "loss": true, "ygc": 0.02, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 2.96, "cash_yi": 25.27, "np_ttm_yi": -3.54, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ null, -2, -2.5, -2.4, -1.4 ], "fcf_avg_yi": -2.075, "ibd_yi": 1.79, "k": 1, "k_src": "equity", "iv_yi": 2.7300000000000004 }, "revenue_ttm_yi": 2.58, "net_margin": -137.2, "roe_by_year": { "2023": 109.0065, "2024": 42.3058, "2025": 229.4585 }, "roe_avg": 126.92, "common_equity_yi": 30.1756, "pb": 3.98, "roe_pb": 31.89, "watched": false }, { "code": "02005", "name": "石四药集团", "l1": "药品及生物科技", "l2": "非H股", "price": 2.75, "market_cap_yi": 67.6, "ev_yi": 97.1, "ee": 21.8, "loss": false, "ygc": 0, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 46.29, "cash_yi": 16.12, "np_ttm_yi": 4.45, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 2.5, 2.8, 2, -0.5, 2.7 ], "fcf_avg_yi": 1.9, "ibd_yi": 35.17, "k": 0.978, "k_src": "profit", "iv_yi": -0.04890000000000069 }, "revenue_ttm_yi": 38.54, "net_margin": 11.5, "roe_by_year": { "2023": 20.0609, "2024": 14.9956, "2025": 6.4821 }, "roe_avg": 13.85, "common_equity_yi": 67.7563, "pb": 1, "roe_pb": 13.88, "watched": false }, { "code": "02268", "name": "药明合联", "l1": "药品及生物科技", "l2": "非H股", "price": 74.45, "market_cap_yi": 805.6, "ev_yi": 829.2, "ee": 53.4, "loss": false, "ygc": 0, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 39.54, "cash_yi": 15.97, "np_ttm_yi": 15.54, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 0.1, 0.5, -2.1, -7.9, 5.2 ], "fcf_avg_yi": -0.8400000000000001, "ibd_yi": 5.32, "k": 1, "k_src": "profit", "iv_yi": 2.25 }, "revenue_ttm_yi": 69.45, "net_margin": 22.4, "roe_by_year": { "2023": 8.1769, "2024": 17.6888, "2025": 17.0515 }, "roe_avg": 14.31, "common_equity_yi": 112.9813, "pb": 7.13, "roe_pb": 2.01, "watched": false }, { "code": "06990", "name": "科伦博泰生物", "l1": "药品及生物科技", "l2": "H股", "price": 452, "market_cap_yi": 920.2, "ev_yi": 902.3, "ee": 597.5, "loss": false, "ygc": -0.01, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 9.85, "cash_yi": 27.76, "np_ttm_yi": 1.51, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -5.8, -3, -0.2, -5.1, -3.1 ], "fcf_avg_yi": -3.44, "ibd_yi": 0.81, "k": 1, "k_src": "equity", "iv_yi": -7.449999999999999 }, "revenue_ttm_yi": 20.86, "net_margin": 7.2, "roe_by_year": { "2023": 128.0564, "2024": -9.4629, "2025": -9.344 }, "roe_avg": 36.42, "common_equity_yi": 53.3685, "pb": 17.24, "roe_pb": 2.11, "watched": false }, { "code": "01951", "name": "锦欣生殖", "l1": "药品及生物科技", "l2": "非H股", "price": 2.195, "market_cap_yi": 49.6, "ev_yi": 90.3, "ee": 52.8, "loss": false, "ygc": -0.02, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 48.59, "cash_yi": 7.6, "np_ttm_yi": 1.71, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 2.6, -4.4, 5.1, 3.7, 3.2 ], "fcf_avg_yi": 2.04, "ibd_yi": 28.94, "k": 0.994, "k_src": "equity", "iv_yi": -0.9343600000000031 }, "revenue_ttm_yi": 27.34, "net_margin": 6.3, "roe_by_year": { "2023": 3.6807, "2024": 2.7801, "2025": -10.0541 }, "roe_avg": -1.2, "common_equity_yi": 89.0687, "pb": 0.56, "roe_pb": -2.15, "watched": false }, { "code": "02335", "name": "麦科医药-B", "l1": "药品及生物科技", "l2": "H股", "price": 24, "market_cap_yi": 67.8, "ev_yi": 60.4, "ee": null, "loss": true, "ygc": -0.02, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 3.22, "cash_yi": 10.68, "np_ttm_yi": -3.64, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ null, null, -1, -1.1, -1.5 ], "fcf_avg_yi": -1.2, "ibd_yi": 0.02, "k": 0.988, "k_src": "equity", "iv_yi": -1.3239199999999998 }, "revenue_ttm_yi": null, "net_margin": null, "roe_by_year": { "2023": 36.3261, "2024": 76.5723, "2025": 42.4115 }, "roe_avg": 51.77, "common_equity_yi": 9.4534, "pb": 7.17, "roe_pb": 7.22, "watched": false }, { "code": "01779", "name": "天辰生物-B", "l1": "药品及生物科技", "l2": "H股", "price": 74.4, "market_cap_yi": 48.4, "ev_yi": 40.8, "ee": null, "loss": true, "ygc": -0.03, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 1.47, "cash_yi": 9.04, "np_ttm_yi": -2.16, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ null, null, -0.6, -1.1, -1.3 ], "fcf_avg_yi": -1, "ibd_yi": 0.56, "k": 1, "k_src": "equity", "iv_yi": -1.5200000000000014 }, "revenue_ttm_yi": null, "net_margin": null, "roe_by_year": { "2023": 49.4494, "2024": 52.4153, "2025": 185.0492 }, "roe_avg": 95.64, "common_equity_yi": 11.2718, "pb": 4.29, "roe_pb": 22.27, "watched": false }, { "code": "06872", "name": "丹诺医药-B", "l1": "药品及生物科技", "l2": "H股", "price": 101.7, "market_cap_yi": 45.3, "ev_yi": 39.2, "ee": null, "loss": true, "ygc": -0.03, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 1.06, "cash_yi": 7.15, "np_ttm_yi": -1.39, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ null, null, -1, -0.5, -0.9 ], "fcf_avg_yi": -0.7999999999999999, "ibd_yi": 0.64, "k": 1, "k_src": "equity", "iv_yi": -1.4899999999999984 }, "revenue_ttm_yi": null, "net_margin": null, "roe_by_year": { "2023": 25.2789, "2024": 17.6141, "2025": 41.1841 }, "roe_avg": 28.03, "common_equity_yi": 6.5488, "pb": 6.92, "roe_pb": 4.05, "watched": false }, { "code": "01558", "name": "东阳光长江药业", "l1": "药品及生物科技", "l2": "H股", "price": 15.88, "market_cap_yi": 119, "ev_yi": 144.2, "ee": 29.8, "loss": false, "ygc": -0.05, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 39.21, "cash_yi": 14.04, "np_ttm_yi": 4.83, "period": "2024-12-31", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -11.3, 9.2, 12.9, -9.9, null ], "fcf_avg_yi": 0.22499999999999964, "ibd_yi": 22.35, "k": 1, "k_src": "equity", "iv_yi": -6.060000000000006 }, "revenue_ttm_yi": 37.24, "net_margin": 13, "roe_by_year": { "2022": 1.3102, "2023": 28.836, "2024": 5.8711 }, "roe_avg": 12.01, "common_equity_yi": 85.082, "pb": 1.4, "roe_pb": 8.58, "watched": false }, { "code": "02315", "name": "百奥赛图-B", "l1": "药品及生物科技", "l2": "H股", "price": 49.16, "market_cap_yi": 335.4, "ev_yi": 339.7, "ee": 92.8, "loss": false, "ygc": -0.05, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 12.16, "cash_yi": 7.9, "np_ttm_yi": 3.66, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -5.6, -5.4, -2, 1.7, 2.8 ], "fcf_avg_yi": -1.7, "ibd_yi": 6.93, "k": 0.998, "k_src": "equity", "iv_yi": -15.997940000000002 }, "revenue_ttm_yi": 16.99, "net_margin": 21.5, "roe_by_year": { "2023": -39.6399, "2024": 4.1411, "2025": 11.5122 }, "roe_avg": -8, "common_equity_yi": 24.2163, "pb": 13.85, "roe_pb": -0.58, "watched": false }, { "code": "03696", "name": "英矽智能", "l1": "药品及生物科技", "l2": "非H股", "price": 39.1, "market_cap_yi": 194.9, "ev_yi": 175.5, "ee": null, "loss": true, "ygc": -0.07, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 4.95, "cash_yi": 24.36, "np_ttm_yi": -20.97, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -2.5, -4.1, -2.3, -4.2, -5.6 ], "fcf_avg_yi": -3.7399999999999993, "ibd_yi": 1.34, "k": 1, "k_src": "equity", "iv_yi": -14.379999999999995 }, "revenue_ttm_yi": 9.23, "net_margin": -227.2, "roe_by_year": { "2023": 38.4905, "2024": 2.602, "2025": 332.5351 }, "roe_avg": 124.54, "common_equity_yi": 37.2594, "pb": 5.23, "roe_pb": 23.81, "watched": false }, { "code": "09969", "name": "诺诚健华", "l1": "药品及生物科技", "l2": "非H股", "price": 12.32, "market_cap_yi": 227.9, "ev_yi": 214.8, "ee": 23.4, "loss": false, "ygc": -0.07, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 35.31, "cash_yi": 48.44, "np_ttm_yi": 9.19, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 0, -9.4, -9.3, -4.4, 0.1 ], "fcf_avg_yi": -4.6, "ibd_yi": 19.01, "k": 0.998, "k_src": "equity", "iv_yi": -16.536860000000008 }, "revenue_ttm_yi": 27.81, "net_margin": 33, "roe_by_year": { "2023": -8.5624, "2024": -6.3523, "2025": 8.891 }, "roe_avg": -2.01, "common_equity_yi": 76.7102, "pb": 2.97, "roe_pb": -0.68, "watched": false }, { "code": "03759", "name": "康龙化成", "l1": "药品及生物科技", "l2": "H股", "price": 26.4, "market_cap_yi": 618.1, "ev_yi": 718.2, "ee": 41.9, "loss": false, "ygc": -0.08, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 118.96, "cash_yi": 14.57, "np_ttm_yi": 17.13, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -0.3, -8.1, -1.1, 5.4, 5.5 ], "fcf_avg_yi": 0.2800000000000001, "ibd_yi": 69.54, "k": 0.959, "k_src": "equity", "iv_yi": -50.03103000000001 }, "revenue_ttm_yi": 152.5, "net_margin": 11.2, "roe_by_year": { "2023": 13.8591, "2024": 13.7022, "2025": 11.6018 }, "roe_avg": 13.05, "common_equity_yi": 163.4877, "pb": 3.78, "roe_pb": 3.45, "watched": false }, { "code": "06938", "name": "瑞博生物-B", "l1": "药品及生物科技", "l2": "H股", "price": 50.6, "market_cap_yi": 73.1, "ev_yi": 61.2, "ee": null, "loss": true, "ygc": -0.08, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 9.76, "cash_yi": 22.42, "np_ttm_yi": -1.7, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ null, null, -3.3, -0.8, -2.9 ], "fcf_avg_yi": -2.3333333333333335, "ibd_yi": 5.43, "k": 0.939, "k_src": "equity", "iv_yi": -5.95639 }, "revenue_ttm_yi": 4.64, "net_margin": -36.6, "roe_by_year": { "2023": -407.5555, "2024": 10275.8083, "2025": 272.2092 }, "roe_avg": 3380.15, "common_equity_yi": 17.2953, "pb": 4.23, "roe_pb": 799.74, "watched": false }, { "code": "08247", "name": "中生北控生物科技", "l1": "药品及生物科技", "l2": "H股 · 创业板", "price": 3.13, "market_cap_yi": 3.9, "ev_yi": 6.5, "ee": null, "loss": true, "ygc": -0.09, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 2.74, "cash_yi": 0.18, "np_ttm_yi": -0.41, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 0.4, 0.3, -0.2, 0.1, -0.3 ], "fcf_avg_yi": 0.06, "ibd_yi": 1.14, "k": 1, "k_src": "equity", "iv_yi": -0.35999999999999993 }, "revenue_ttm_yi": 1.71, "net_margin": -24, "roe_by_year": { "2023": -5.5968, "2024": -22.4923, "2025": -35.5168 }, "roe_avg": -21.2, "common_equity_yi": 1.118, "pb": 3.49, "roe_pb": -6.08, "watched": false }, { "code": "03378", "name": "翰思艾泰-B", "l1": "药品及生物科技", "l2": "H股", "price": 27.02, "market_cap_yi": 30.9, "ev_yi": 27.8, "ee": null, "loss": true, "ygc": -0.11, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 1.65, "cash_yi": 5, "np_ttm_yi": -1.31, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ null, -0.5, -0.6, -1.1, -1 ], "fcf_avg_yi": -0.8, "ibd_yi": 0.74, "k": 0.922, "k_src": "equity", "iv_yi": -3.4482800000000005 }, "revenue_ttm_yi": null, "net_margin": null, "roe_by_year": { "2023": -40.9036, "2024": -53.3328, "2025": -30.3265 }, "roe_avg": -41.52, "common_equity_yi": 6.3251, "pb": 4.89, "roe_pb": -8.5, "watched": false }, { "code": "09887", "name": "维立志博-B", "l1": "药品及生物科技", "l2": "H股", "price": 41.3, "market_cap_yi": 70, "ev_yi": 67.5, "ee": null, "loss": true, "ygc": -0.13, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 6.08, "cash_yi": 8.59, "np_ttm_yi": -2.67, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ null, -0.7, -2, -1.2, -1.6 ], "fcf_avg_yi": -1.375, "ibd_yi": 3.73, "k": 1, "k_src": "equity", "iv_yi": -8.89 }, "revenue_ttm_yi": null, "net_margin": null, "roe_by_year": { "2023": 46.5851, "2024": 88.1722, "2025": -27.6117 }, "roe_avg": 35.72, "common_equity_yi": 9.3083, "pb": 7.52, "roe_pb": 4.75, "watched": false }, { "code": "01548", "name": "金斯瑞生物-一千", "l1": "药品及生物科技", "l2": "非H股", "price": 33.3, "market_cap_yi": 647.7, "ev_yi": 695.2, "ee": null, "loss": true, "ygc": -0.19, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 60.91, "cash_yi": 13.37, "np_ttm_yi": -44.44, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -17.4, -22.6, -31.5, -5.2, 17 ], "fcf_avg_yi": -11.940000000000001, "ibd_yi": 17.26, "k": 0.999, "k_src": "equity", "iv_yi": -123.16671 }, "revenue_ttm_yi": 57.84, "net_margin": -76.8, "roe_by_year": { "2023": -7.951, "2024": 103.7026, "2025": -12.8695 }, "roe_avg": 27.63, "common_equity_yi": 264.7817, "pb": 2.45, "roe_pb": 11.29, "watched": false }, { "code": "02595", "name": "劲方医药-B", "l1": "药品及生物科技", "l2": "H股", "price": 27.86, "market_cap_yi": 90.8, "ev_yi": 88.5, "ee": null, "loss": true, "ygc": -0.19, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 3.34, "cash_yi": 5.69, "np_ttm_yi": -13.16, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ null, -3, -2, -2.1, -1.4 ], "fcf_avg_yi": -2.125, "ibd_yi": 1.39, "k": 1, "k_src": "equity", "iv_yi": -16.95 }, "revenue_ttm_yi": 0.84, "net_margin": -1566.7, "roe_by_year": { "2023": 46.98, "2024": 41.4007, "2025": 2533.4453 }, "roe_avg": 873.94, "common_equity_yi": 16.0611, "pb": 5.65, "roe_pb": 154.59, "watched": false }, { "code": "09926", "name": "康方生物", "l1": "药品及生物科技", "l2": "非H股", "price": 91.3, "market_cap_yi": 731.8, "ev_yi": 799.8, "ee": null, "loss": true, "ygc": -0.19, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 78.57, "cash_yi": 10.54, "np_ttm_yi": -9.67, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -17.2, -20.4, 15.9, -11.2, -17.3 ], "fcf_avg_yi": -10.039999999999997, "ibd_yi": 49.85, "k": 1, "k_src": "equity", "iv_yi": -139.70999999999998 }, "revenue_ttm_yi": 34.5, "net_margin": -28, "roe_by_year": { "2023": 55.3578, "2024": -8.9432, "2025": -14.034 }, "roe_avg": 10.79, "common_equity_yi": 84.8645, "pb": 8.62, "roe_pb": 1.25, "watched": false }, { "code": "02630", "name": "旺山旺水-B", "l1": "药品及生物科技", "l2": "H股", "price": 80, "market_cap_yi": 114.2, "ev_yi": 121.4, "ee": null, "loss": true, "ygc": -0.22, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 10.31, "cash_yi": 3.08, "np_ttm_yi": -3.05, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ null, null, -1.3, -2, -2.6 ], "fcf_avg_yi": -1.9666666666666668, "ibd_yi": 8.58, "k": 1, "k_src": "equity", "iv_yi": -25.16666666666667 }, "revenue_ttm_yi": 2.17, "net_margin": -140.6, "roe_by_year": { "2023": 6.072, "2024": -121.2895, "2025": -119.4242 }, "roe_avg": -78.21, "common_equity_yi": 2.1452, "pb": 53.24, "roe_pb": -1.47, "watched": false }, { "code": "02696", "name": "复宏汉霖", "l1": "药品及生物科技", "l2": "H股", "price": 51.35, "market_cap_yi": 238.5, "ev_yi": 319.7, "ee": 36.9, "loss": false, "ygc": -0.22, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 85.58, "cash_yi": 4.35, "np_ttm_yi": 8.67, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -10.4, -3.8, 0.4, 4, 1.1 ], "fcf_avg_yi": -1.7399999999999998, "ibd_yi": 39.49, "k": 1, "k_src": "equity", "iv_yi": -52.54 }, "revenue_ttm_yi": 74.35, "net_margin": 11.7, "roe_by_year": { "2023": 28.5229, "2024": 31.5206, "2025": 23.7176 }, "roe_avg": 27.92, "common_equity_yi": 45.385, "pb": 5.26, "roe_pb": 5.31, "watched": false }, { "code": "06160", "name": "百济神州", "l1": "药品及生物科技", "l2": "非H股", "price": 225, "market_cap_yi": 3029.6, "ev_yi": 2942.5, "ee": 65.5, "loss": false, "ygc": -0.23, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 272.55, "cash_yi": 359.66, "np_ttm_yi": 44.95, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -242.6, -138.1, -125.3, -49.5, 59.7 ], "fcf_avg_yi": -99.16, "ibd_yi": 77.86, "k": 1, "k_src": "equity", "iv_yi": -709.7999999999997 }, "revenue_ttm_yi": 420.62, "net_margin": 10.7, "roe_by_year": { "2023": -22.2634, "2024": -18.7723, "2025": 7.4592 }, "roe_avg": -11.19, "common_equity_yi": 352.3958, "pb": 8.6, "roe_pb": -1.3, "watched": false }, { "code": "06887", "name": "东阳光药", "l1": "药品及生物科技", "l2": "H股", "price": 38.46, "market_cap_yi": 188.1, "ev_yi": 251.2, "ee": null, "loss": true, "ygc": -0.24, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 78.01, "cash_yi": 14.79, "np_ttm_yi": -2.85, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -13.9, 3.8, 9.5, -5.6, 3.1 ], "fcf_avg_yi": -0.6200000000000002, "ibd_yi": 53.13, "k": 0.998, "k_src": "equity", "iv_yi": -44.45092 }, "revenue_ttm_yi": 39.53, "net_margin": -7.2, "roe_by_year": { "2023": -11.0049, "2024": -61.7299, "2025": 11.6213 }, "roe_avg": -20.37, "common_equity_yi": 38.6352, "pb": 4.87, "roe_pb": -4.18, "watched": false }, { "code": "09995", "name": "荣昌生物", "l1": "药品及生物科技", "l2": "H股", "price": 65.9, "market_cap_yi": 473, "ev_yi": 473, "ee": 8.1, "loss": false, "ygc": -0.24, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 15.33, "cash_yi": 15.29, "np_ttm_yi": 58.22, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -3.5, -20.2, -23.5, -14.4, -1.5 ], "fcf_avg_yi": -12.620000000000001, "ibd_yi": 3.11, "k": 1, "k_src": "equity", "iv_yi": -114.02000000000004 }, "revenue_ttm_yi": 80, "net_margin": 72.8, "roe_by_year": { "2023": -35.9065, "2024": -54.1484, "2025": 25.3672 }, "roe_avg": -21.56, "common_equity_yi": 83.1408, "pb": 5.69, "roe_pb": -3.79, "watched": false }, { "code": "02228", "name": "晶泰控股", "l1": "药品及生物科技", "l2": "非H股", "price": 5.92, "market_cap_yi": 216.9, "ev_yi": 226.1, "ee": null, "loss": true, "ygc": -0.25, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 35.51, "cash_yi": 26.23, "np_ttm_yi": -2.11, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -4.2, -6.3, -7, -5.4, -2.5 ], "fcf_avg_yi": -5.08, "ibd_yi": 31.18, "k": 0.992, "k_src": "equity", "iv_yi": -55.30399999999999 }, "revenue_ttm_yi": 6.79, "net_margin": -31.1, "roe_by_year": { "2023": 30.3989, "2024": 91.8138, "2025": 1.8542 }, "roe_avg": 41.36, "common_equity_yi": 90, "pb": 2.41, "roe_pb": 17.16, "watched": false }, { "code": "02142", "name": "和铂医药-B", "l1": "药品及生物科技", "l2": "非H股", "price": 10.37, "market_cap_yi": 76.8, "ev_yi": 75.6, "ee": 13.3, "loss": false, "ygc": -0.26, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 7.87, "cash_yi": 9.08, "np_ttm_yi": 5.7, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -8.9, -8.2, -1.5, 2.2, 4.9 ], "fcf_avg_yi": -2.3000000000000003, "ibd_yi": 6.11, "k": 1, "k_src": "equity", "iv_yi": -20.03 }, "revenue_ttm_yi": 12.19, "net_margin": 46.8, "roe_by_year": { "2023": 21.4243, "2024": 2.273, "2025": 37.1596 }, "roe_avg": 20.29, "common_equity_yi": 28.4598, "pb": 2.7, "roe_pb": 7.52, "watched": false }, { "code": "01652", "name": "福森药业", "l1": "药品及生物科技", "l2": "非H股", "price": 0.865, "market_cap_yi": 5.4, "ev_yi": 13.5, "ee": null, "loss": true, "ygc": -0.27, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 8.97, "cash_yi": 0.88, "np_ttm_yi": -0.02, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -0.6, 0.8, -1.1, 0.6, 0.7 ], "fcf_avg_yi": 0.07999999999999999, "ibd_yi": 3.14, "k": 1, "k_src": "equity", "iv_yi": -1.4600000000000004 }, "revenue_ttm_yi": 2.76, "net_margin": -0.7, "roe_by_year": { "2023": -6.1607, "2024": -40.4598, "2025": -3.2333 }, "roe_avg": -16.62, "common_equity_yi": 3.4561, "pb": 1.56, "roe_pb": -10.64, "watched": false }, { "code": "01763", "name": "中国同辐", "l1": "药品及生物科技", "l2": "H股", "price": 12.19, "market_cap_yi": 33.2, "ev_yi": 58.6, "ee": 18, "loss": false, "ygc": -0.29, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 77.33, "cash_yi": 25.41, "np_ttm_yi": 3.26, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 3.7, 2.9, -8.1, -8.9, -0.3 ], "fcf_avg_yi": -2.14, "ibd_yi": 23.6, "k": 0.489, "k_src": "profit", "iv_yi": -9.579509999999999 }, "revenue_ttm_yi": 73.14, "net_margin": 4.5, "roe_by_year": { "2023": 8.098, "2024": 8.3856, "2025": 6.4 }, "roe_avg": 7.63, "common_equity_yi": 53.0893, "pb": 0.63, "roe_pb": 12.2, "watched": false }, { "code": "02256", "name": "和誉-B", "l1": "药品及生物科技", "l2": "非H股", "price": 7.75, "market_cap_yi": 47.3, "ev_yi": 43.7, "ee": null, "loss": true, "ygc": -0.32, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 5.15, "cash_yi": 8.71, "np_ttm_yi": -4.67, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -1.8, -3.7, -4.6, -0.2, 0.7 ], "fcf_avg_yi": -1.92, "ibd_yi": 4.55, "k": 1, "k_src": "equity", "iv_yi": -15.04 }, "revenue_ttm_yi": 0.97, "net_margin": -481.4, "roe_by_year": { "2023": -19.9461, "2024": 1.4369, "2025": 2.8469 }, "roe_avg": -5.22, "common_equity_yi": 21.802, "pb": 2.17, "roe_pb": -2.41, "watched": false }, { "code": "00013", "name": "和黄医药", "l1": "药品及生物科技", "l2": "非H股", "price": 22.28, "market_cap_yi": 165.5, "ev_yi": 189.4, "ee": 300.6, "loss": false, "ygc": -0.35, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 31.43, "cash_yi": 7.26, "np_ttm_yi": 0.63, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -14.1, -21.3, 13.2, -1.3, -6.2 ], "fcf_avg_yi": -5.9399999999999995, "ibd_yi": 6.44, "k": 0.989, "k_src": "equity", "iv_yi": -57.93561999999999 }, "revenue_ttm_yi": 37.63, "net_margin": 1.7, "roe_by_year": { "2023": 15.0316, "2024": 5.0627, "2025": 45.74 }, "roe_avg": 21.94, "common_equity_yi": 85.8702, "pb": 1.93, "roe_pb": 11.39, "watched": false }, { "code": "00348", "name": "中国智能健康", "l1": "药品及生物科技", "l2": "非H股", "price": 0.073, "market_cap_yi": 0.6, "ev_yi": 1.6, "ee": null, "loss": true, "ygc": -0.35, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 1.07, "cash_yi": 0.07, "np_ttm_yi": -0.29, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ 0.3, -0.3, 0.1, 0, 0.1 ], "fcf_avg_yi": 0.04, "ibd_yi": 0.68, "k": 1, "k_src": "none", "iv_yi": -0.21000000000000002 }, "revenue_ttm_yi": 0.75, "net_margin": -38.7, "roe_by_year": { "2023": -188.1312, "2024": 576.1837, "2025": 13.2378 }, "roe_avg": 133.76, "common_equity_yi": -0.4351, "pb": null, "roe_pb": null, "watched": false }, { "code": "02162", "name": "康诺亚-B", "l1": "药品及生物科技", "l2": "非H股", "price": 81.95, "market_cap_yi": 208.5, "ev_yi": 201.7, "ee": 26.1, "loss": false, "ygc": -0.36, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 16.63, "cash_yi": 23.39, "np_ttm_yi": 7.74, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -5.7, -13.1, -6.9, -10, -10.5 ], "fcf_avg_yi": -9.24, "ibd_yi": 6.97, "k": 1, "k_src": "equity", "iv_yi": -75.98 }, "revenue_ttm_yi": 8.35, "net_margin": 92.7, "roe_by_year": { "2023": -11.3602, "2024": -18.8702, "2025": -19.9146 }, "roe_avg": -16.71, "common_equity_yi": 40.0573, "pb": 5.21, "roe_pb": -3.21, "watched": false }, { "code": "06127", "name": "昭衍新药", "l1": "药品及生物科技", "l2": "H股", "price": 27.44, "market_cap_yi": 334.9, "ev_yi": 345.2, "ee": 35.1, "loss": false, "ygc": -0.36, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 18.51, "cash_yi": 8.24, "np_ttm_yi": 9.84, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -20.7, 0.5, -1.3, -26.9, -15.8 ], "fcf_avg_yi": -12.84, "ibd_yi": 0.32, "k": 1, "k_src": "profit", "iv_yi": -120.48 }, "revenue_ttm_yi": 16.93, "net_margin": 58.1, "roe_by_year": { "2023": 4.8228, "2024": 0.9057, "2025": 3.6314 }, "roe_avg": 3.12, "common_equity_yi": 89.7497, "pb": 3.73, "roe_pb": 0.84, "watched": false }, { "code": "09966", "name": "康宁杰瑞制药-B", "l1": "药品及生物科技", "l2": "非H股", "price": 6.9, "market_cap_yi": 56.8, "ev_yi": 57.9, "ee": null, "loss": true, "ygc": -0.37, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 4.91, "cash_yi": 3.82, "np_ttm_yi": -1.76, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -4.8, -4.3, -2.4, 1.9, -1.5 ], "fcf_avg_yi": -2.2199999999999998, "ibd_yi": 2.68, "k": 1, "k_src": "equity", "iv_yi": -21.059999999999995 }, "revenue_ttm_yi": 5.18, "net_margin": -34, "roe_by_year": { "2023": -13.0407, "2024": 9.4944, "2025": -6.4322 }, "roe_avg": -3.33, "common_equity_yi": 16.7328, "pb": 3.39, "roe_pb": -0.98, "watched": false }, { "code": "01672", "name": "歌礼制药-B", "l1": "药品及生物科技", "l2": "非H股", "price": 5.85, "market_cap_yi": 52.4, "ev_yi": 48.3, "ee": null, "loss": true, "ygc": -0.41, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 1.81, "cash_yi": 5.93, "np_ttm_yi": -5.92, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -1.5, -2.2, -2.4, -3.4, -4.2 ], "fcf_avg_yi": -2.7399999999999998, "ibd_yi": 0.04, "k": 1, "k_src": "equity", "iv_yi": -21.509999999999998 }, "revenue_ttm_yi": null, "net_margin": null, "roe_by_year": { "2023": -5.9286, "2024": -13.9703, "2025": -18.4534 }, "roe_avg": -12.78, "common_equity_yi": 22.7095, "pb": 2.31, "roe_pb": -5.54, "watched": false }, { "code": "03839", "name": "正大生物", "l1": "药品及生物科技", "l2": "非H股", "price": 7.9, "market_cap_yi": 16.2, "ev_yi": 24.9, "ee": 14.9, "loss": false, "ygc": -0.43, "triggered": false, "fcf_growth": [], "detail": { "total_liabilities_yi": 12.2, "cash_yi": 2.54, "np_ttm_yi": 1.67, "period": "2026-06-30", "fcf_years": [ "2021", "2022", "2023", "2024", "2025" ], "fcf_by_year": [ -1.8, -0.7, -1.9, -0.2, 2 ], "fcf_avg_yi": -0.5200000000000001, "ibd_yi": 5.15, "k": 0.9, "k_src": "equity", "iv_yi": -7.029000000000002 }, "revenue_ttm_yi": 28.92, "net_margin": 5.8, "roe_by_year": { "2023": 1.1117, "2024": 4.8221, "2025": 12.5235 }, "roe_avg": 6.15, "common_equity_yi": 20.0087, "pb": 0.81, "roe_pb": 7.6, "watched": false } ] }